Cart
sales@molnova.com
Methyl Ergoline Acid
CAS No. 4579-64-0
Methyl Ergoline Acid( —— )
Catalog No. M28908 CAS No. 4579-64-0
Methyl Ergoline Acid, an ergoline derivative, can be used as chemokine receptor ligands.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | 737 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl Ergoline Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl Ergoline Acid, an ergoline derivative, can be used as chemokine receptor ligands.
-
DescriptionMethyl Ergoline Acid, an ergoline derivative, can be used as chemokine receptor ligands.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number4579-64-0
-
Formula Weight282.34
-
Molecular FormulaC17H18N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C1)[C@H](Cc2c[nH]c3cccc4c23)C4=C[C@H]1C(OC)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Auclair AL, Kleven MS, Barret-Grévoz C, Barreto M, Newman-Tancredi A, Depoortère R. Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. Behav Brain Res. 2009 N
molnova catalog
related products
-
C14 Ceramide (d18:1/...
C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's research.
-
CLIP (human) (TFA)
Adrenocorticotropic Hormone (ACTH) (18-39), human TFA is a corticotropinlike intermediate lobe peptide, which is is produced in the melanotrophs of the intermediate lobe of the pituitary.
-
Thalidomide-O-amido-...
Thalidomide-O-amido-PEG-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs.
